查詢結果分析
相關文獻
- 小柴胡加減方對慢性C型病毒性肝炎之治療效果
- 持續性及循環性全靜脈營養方式對大白鼠身體組成及肝臟功能的改變
- 肝切除:術前肝功能評估及術後肝衰竭
- 川崎病之肝功能回顧研究
- 最大漸增運動對健康B型肝炎帶原者肝功能的影響
- Pharmacological Functions of Chinese Medicinal Fungus Cordyceps sinensis and Related Species
- Alstrom Syndrome with Hepatic Dysfunction: Report of One Case
- 洛克沙生對肉雞生長性狀、肝臟機能及腿部疾病之影響
- 灌食不同劑量與製程的兒茶素類物質對小鼠抗氧化能力與肝功能之影響
- 大棗的藥性與養生
頁籤選單縮合
題 名 | 小柴胡加減方對慢性C型病毒性肝炎之治療效果 |
---|---|
編 次 | 1 |
作 者 | 牟聯瑞; | 書刊名 | 中醫藥年報 |
卷 期 | 15:1 1997.05[民86.05] |
頁 次 | 頁64-74 |
分類號 | 413.4 |
關鍵詞 | 小柴胡加減方; C型病毒性肝炎; 肝功能; Modified xiao-chaihu-tang; C virus hepatitis; Anti-HCV; HCV-RNA; |
語 文 | 中文(Chinese) |
中文摘要 | 為了開發對慢性C型肝炎有效的治療中葯方劑, 我們由文獻中篩選出含柴胡、黃 芩、甘草、白芍、白朮、茯苓與丹參的方劑,命名為小柴胡湯加減方。 我們擬由中西醫合 作,評估此方劑對慢性 C 型肝炎的治療效果。 研究對象為肝功能指數不正常超過半年以上 之 C 型肝炎患者共 60 名,分成兩組即控制組及治療組。 控制組給與綜合維他命 B,治療 組則給與小柴胡加減方合併綜合維他命 B。 藥物投與期間為 9 個月,在治療期間每個月觀 察肝功能 (包括 GOT、GPT、 albumin、 total bilirubin) 的變化。 每兩個月觀察血清中 anti-HCV titer 及治療前後以 PCR 法測定 HCV-RNA, 於研究結束時控制組中有 4 名脫失 未完成評估。研究結果顯示,治療前兩組之間的 GOT 及 GPT 值並無明顯差異,而於小柴胡 加減方投與第 4 個月以後,j 台療組的 GOT、GPT 值則明顯低於控制組 (P<O.05)。治療結 束時,控制組與治療組的 GOT 值分別為 114 土 32U/L 及 72 土 30U/L (P<O.05)。另一方 面,兩組的 GPT 值則分別為 136 土 38U/L 及 90 土 36U/L (P<O.05)。 30 名治療組中有 7 名 (23%),而 26 名控制組中有 4 名 (15%) 肝功能指數完全恢復正常。 除了 GOT、GPT 值以外, 其他血清 albumin、Bilirubin (T) 值並無顯著差異。 以 PCR 法測定血清 HCV- RNA 則全例於治療結束時皆呈陽性反應。服用小柴胡加減方 30 名患者中有 3 名 (l0%) 於 初期出現一過性腸胃不適及輕微腹瀉,除此之外並無其他副作用。由以上的結果顯示小柴胡 湯雖不能消減 C 型肝炎病毒,卻是一種能改善肝功能的安全藥物,值得作為慢性 C 型肝炎 的支持性療法。 |
英文摘要 | In order to develop new effective prescriptions of chinese herb drugs for chronic C virus hepatitis, we made a new prescription, namely modifled Xiao- Chaihu-tang (MXCT ). It included seven kinds of herb drugs as Bupleuri radix, Scutellariae Radix, Glycyrrhizine Radix, Paeonial Radix, Atractyloidis rhizoma, Poriae, and Salviae Miltiorrhiza Radix. The western medical doctors cooperated with Chinese medical doctors to evaluate the effect of MXCT in patients with chronic C virus hepatitis. Studied subjects included sixty patients who had been diagnosed chronic C virus hepatitis with abnormal liver function for more than half year. They were divided into a control group and a treatment group. The patients in control group were given vitamine B complex. Whereas the patients in treatment group were given MXCT combined with vitamine B complex for 9 months. Each subject was followed up liver function including serum GOT, GPT, albumin and total bilirubin for every month, serum anti-HCV titer for every two months and HCV-RNA by PCR methi~d before and after treatment. At the end of study, four patients in control group were lost of study. After treatment for nine months, the results showed that the serum levels of GOT and GPT were similar in these two groups. However, after the treatment for four months, both serum levels of GOT and GPT in control group were significantly greater than those in treatment group. The serum levels of GOT in control and treatment groups were 114 ± 32U/L and 72 ± 30U/L, respectively (p<0.05). On the other hand, the serum levels of GPT in control and treatment groups were 136 ± 38 U/L and 90 ± 36 U/L, respectively (p<0.05). Among the effective cases, seven of thirty patients in treatment group (7/30, 23%) and four of twenty six patients in control group (4/26, 15%) had normal serum levels of GOT and GPT at the end of study. Unlike GOT and GPT, there was no significant difference in the serum level of albumin and total bilirubin between two grops. Similarly, there was no significant change in the serum titer of Anti-HCV and HCV-RNA in both groups after treatment. All of the studied cases had positive results for serum Anti-HCV and HCV-RNA. Three of thirty patients in treatment group had side effect with temporarily, epigastric discomfort and diarrhea but tolerated in slight degree in the beginning of treatment. Except above symptoms, no other side-effects were found. The above rsults revealed that although MXCT could not elimination of C hepatitis virus, it is a safety drug for improvement of live function and is worthful as a supportive treatment for chronic C hepatitis. |
本系統中英文摘要資訊取自各篇刊載內容。